Clinical Trials Browser

Completed × Lymphoma, Non-Hodgkin × tositumomab I-131 × Clear all

NCT00006695 2023-09-01

Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

NCT00329030 2021-11-01

BMTCTN0401

Phase 3 Completed

224 enrolled 24 charts

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic

NCT00777114 2018-08-13

Phase 1 Study of Radiosensitization Using Bortezomib in Relapsed Non-Hodgkin's Lymphoma Patients Receiving Radioimmunotherapy

Phase 1 Completed

Lymphoma, Non-Hodgkin

NCT01536561 2017-08-31

Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma

Phase 1 Completed

59 enrolled 27 charts

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT00992758 2017-07-25

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement

Phase 1 Completed

Lymphoma, Non-Hodgkin

NCT00950755 2017-01-18

Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology

Phase 2 Completed

41 enrolled 25 charts

Lymphoma, Non-Hodgkin

NCT00996996 2017-01-11

Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's Lymphoma

Phase 2 Completed

77 enrolled 34 charts

Lymphoma, Non-Hodgkin

NCT00268983 2017-01-09

Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma

Phase 3 Completed

14 enrolled 20 charts

Lymphoma, Non-Hodgkin

NCT00938041 2017-01-09

Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody

Phase 2 Completed

32 enrolled 11 charts

Lymphoma, Non-Hodgkin

NCT00989664 2016-12-13

Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma

Phase 2 Completed

60 enrolled 26 charts

Lymphoma, Lymphoma, Non-Hodgkin

NCT01224821 2016-12-12

RIT-II-001

Phase 2 Completed

47 enrolled 22 charts

Lymphoma, Non-Hodgkin

NCT00996593 2016-11-23

Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab

Phase 2 Completed

43 enrolled 28 charts

Lymphoma, Non-Hodgkin

NCT00434629 2016-08-17

Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant

Phase 1 Completed

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT00073931 2015-02-05

Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 2 Completed

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00062894 2007-09-17

Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab

Phase 1/2 Completed

Lymphoma, Non-Hodgkin